RedHill Biopharma (Israel) Profile

407.40
ILS 0.1  0.02%
99%
62%

RedHill Biopharma Summary

RedHill Biopharma Ltd (RDHL) is traded on Tel Aviv Stock Exchange in Israel. It is located in 21 Ha'arba'a Street and employs 74 people. The company currently falls under 'Small-Cap' category with current market capitalization of 619.61 M. RedHill Biopharma Ltd has 213.44 M outstanding shares. REDHILL BIOPHARMA has accumulated about 46.2 M in cash with (44.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22.
Check RedHill Biopharma Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 407.4HorizonTargetOdds Above 407.4
96.94%30 days 407.40 3.04%
Based on normal probability distribution, the odds of RedHill Biopharma to move above current price in 30 days from now is under 4% (This RedHill Biopharma Ltd probability density function shows the probability of RedHill Biopharma Stock to fall within a particular range of prices over 30 days) .

RedHill Biopharma Risk Profiles

Key Fundamentals

RedHill Biopharma Against Markets

Current Ratings

RedHill Biopharma 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
38 
Chance of
Financial Distress (0 to 100%)
21 
Equity ratings for RedHill Biopharma Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on the development and commercialization of late clinical-stage, proprietary, and in-licensedacquired drugs for the treatment of gastrointestinal and inflammatory diseases, and cancer. The company was founded in 2009 and is headquartered in Tel Aviv, Israel. RedHill Biopharma operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 74 people. more
NameRedHill Biopharma Ltd
CEOOri ShiloView All
Macroaxis Advice
InstrumentIsrael Stock View All
Business Address21 Ha'arba'a Street
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
SectorHealthcare
BenchmarkDOW
Websitewww.redhillbio.com
Phone972 3 541 3131
CurrencyILS - Israeli Shekel

RedHill Biopharma Corporate Directors

Ofer Tsimchi Director
Shmuel Cabilly Director
Kenneth Reed Director, Ph.D
Additionally take a look at Your Equity Center. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.